AstraZeneca boosts open innovation efforts


Astrazeneca (AZ) has launched a new web portal, bringing together new and existing open innovation programmes. The aim is to make collaboration with academics, other companies, governments and non-government organisations easier.

Like a growing number of pharmaceutical companies, AZ already collaborates extensively with academics and other organisation. However, it wants to open up these programmes and encourage potential collaborators. AZ will offer access to its compound library, tool compounds for biological investigations, screening for target validation and various other services. There will also be rewards for researchers who suggest solutions for challenges the company is facing.

‘To push the boundaries of science and deliver new medicines to patients, we need to create a more permeable research environment,’ said AZ’s Mene Pangalos in a statement. ‘An essential part of that is making our knowledge and compounds more accessible.’

This move follows several similar initiatives from other companies: most notably GlaxoSmithKline, which has opened up extensive chunks of its compound libraries and runs collaborative drug discovery contests; Eli Lilly, which has ongoing target-based and phenotypic screening services available to potential collaborators; and a consortium of Japanese firms.


Related Content

The hunt for innovation

31 January 2014 Premium contentFeature

news image

Big pharma companies are embracing a more open and collaborative approach. Nuala Moran discovers who’s working with whom

Data-sharing partnership for drug discovery

28 June 2013 Business

news image

Collaborative project aims to assist medicinal chemistry efforts

Most Read

Perovskite solar cells show hydrogen production promise

26 September 2014 Research

news image

Highly efficient solar cells and catalysts made from cheap, common materials use sunlight to split water

Big name coffee chains drawn into acrylamide fight

23 September 2014 News and Analysis

news image

Starbucks and other coffee chains are being sued in California by a non-profit that wants carcinogen labels slapped on their ...

Most Commented

Perovskite solar cells show hydrogen production promise

26 September 2014 Research

news image

Highly efficient solar cells and catalysts made from cheap, common materials use sunlight to split water

First interstellar sighting of a branched alkyl molecule

25 September 2014 Research

news image

Discovery shows that stellar nurseries could hold amino acids too that might have been the spark for life on Earth